Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Zynex stock

Learn how to easily invest in Zynex stock.

Zynex Inc
- $0.08 ( - 0.95%)

Zynex Inc is a medical distribution business based in the US. Zynex shares (ZYXI) are listed on the NASDAQ and all prices are listed in US Dollars. Zynex employs 768 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in Zynex

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – ZYXI – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Zynex stock price (NASDAQ: ZYXI)

Use our graph to track the performance of ZYXI stocks over time.

Zynex shares at a glance

Information last updated 2022-01-16.
Latest market close$8.42
52-week range$7.59 - $18.69
50-day moving average $10.72
200-day moving average $12.39
Wall St. target price$20.18
PE ratio 31.9216
Dividend yield N/A (0.88%)
Earnings per share (TTM) $0.26

Buy Zynex shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
M1 Finance
Free 1-year trial of M1 Plus
when you sign up for M1 Finance
Invest in your favorite stocks or in curated portfolios with automatic rebalancing.
SoFi Invest
Stocks, ETFs, Cryptocurrency
Get one free stock worth up to $1,000
Open an account
A free way to invest in most equities.
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency
$0 + $0.50/contract
$0 per month
$10 of crypto
Open an account with access to crypto
A platform built for all kinds of traders and all styles of trading
Stocks, Options, ETFs, Cryptocurrency
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Stash Invest
Stocks, ETFs
$1 per month
Add at least $5 to your Invest account
Stash is more than an investment app. You’ll have access to tools that can help you become a confident investor.
Stocks, ETFs, Cryptocurrency
$0 per month
Download and sign up with; approved accounts receive a free stock slice worth up to $300, selected from 9 popular stocks.
Open an account
Commission-free trading in stocks and ETFs with a social networking twist.

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Zynex stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Zynex price performance over time

Historical closes compared with the close of $8.42 from 2022-01-19

1 week (2022-01-13) 0.24%
1 month (2021-12-20) -13.91%
3 months (2021-10-21) -31.71%
6 months (2021-07-21) -49.46%
1 year (2021-01-21) -48.41%
2 years (2020-01-17) -13.36%
3 years (2019-01-18) 178.14%
5 years (2017-01-20) 2,952.94%

Is Zynex stock undervalued or overvalued?

Valuing Zynex stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Zynex's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Zynex's P/E ratio

Zynex's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 32x. In other words, Zynex shares trade at around 32x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

Zynex's EBITDA

Zynex's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $15.3 million.

The EBITDA is a measure of a Zynex's overall financial performance and is widely used to measure a its profitability.

Zynex financials

Revenue TTM $115.5 million
Operating margin TTM 11.32%
Gross profit TTM $63.4 million
Return on assets TTM 10.5%
Return on equity TTM 17%
Profit margin 8.65%
Book value $1.64
Market capitalisation $326.4 million

TTM: trailing 12 months

Zynex share dividends


Dividend payout ratio: 35.01% of net profits

Recently Zynex has paid out, on average, around 35.01% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Zynex shareholders could enjoy a 0% return on their shares, in the form of dividend payments. In Zynex's case, that would currently equate to about $N/A per share.

While Zynex's payout ratio might seem fairly standard, it's worth remembering that Zynex may be investing much of the rest of its net profits in future growth.

Zynex's most recent dividend payout was on 20 January 2022. The latest dividend was paid out to all shareholders who bought their shares by 4 January 2022 (the "ex-dividend date").

Have Zynex's shares ever split?

Zynex's shares were split on a 11:10 basis on 4 January 2022. So if you had owned 10 shares the day before before the split, the next day you'd have owned 11 shares. This wouldn't directly have changed the overall worth of your Zynex shares – just the quantity. However, indirectly, the new 9.1% lower share price could have impacted the market appetite for Zynex shares which in turn could have impacted Zynex's share price.

Zynex share price volatility

Over the last 12 months, Zynex's shares have ranged in value from as little as $7.5932 up to $18.6891. A popular way to gauge a stock's volatility is its "beta".

ZYXI.US volatility(beta: 0.77)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Zynex's is 0.7734. This would suggest that Zynex's shares are less volatile than average (for this exchange).

Zynex overview

Zynex, Inc. , through its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. It offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation (TENS), and neuromuscular electrical stimulation (NMES) device; NeuroMove, an electromyography triggered electrical stimulation device; InWave, an electrical stimulation product for the treatment of female urinary incontinence; and E-Wave, an NMES device. The company also supplies electrodes for the delivery of electrical current to the body, and batteries for use in electrotherapy products; and distributes Comfortrac/Saunders for cervical traction, JetStream for hot/cold therapy, and LSO Back Braces for lumbar support. In addition, it offers CM-1500, a blood volume monitor device for monitoring central blood volume for use in operating and recovery rooms to detect blood loss during surgery and internal bleeding during recovery. The company provides its products for use in pain management and control; and stroke and spinal cord injury rehabilitation. Zynex, Inc.

Frequently asked questions

What percentage of Zynex is owned by insiders or institutions?
Currently 45.749% of Zynex shares are held by insiders and 32.616% by institutions.
How many people work for Zynex?
Latest data suggests 768 work at Zynex.
When does the fiscal year end for Zynex?
Zynex's fiscal year ends in December.
Where is Zynex based?
Zynex's address is: 9555 Maroon Circle, Englewood, CO, United States, 80112
What is Zynex's ISIN number?
Zynex's international securities identification number is: US98986M1036
What is Zynex's CUSIP number?
Zynex's Committee on Uniform Securities Identification Procedures number is: 98986M103

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site